DBG
De Burlo Group Portfolio holdings
AUM
$759M
This Quarter Return
-6.47%
1 Year Return
+24.77%
3 Year Return
+146.35%
5 Year Return
+326.03%
10 Year Return
+1,922.48%
AUM
$445M
AUM Growth
+$445M
(-16%)
Cap. Flow
-$62.4M
Cap. Flow
% of AUM
-14.01%
Top 10 Holdings %
Top 10 Hldgs %
44.55%
Holding
123
New
13
Increased
20
Reduced
42
Closed
33
Top Buys
| 1 |
PayPal
PYPL
|
$32.3M |
| 2 |
Procter & Gamble
PG
|
$13.1M |
| 3 |
Merck
MRK
|
$11.7M |
| 4 |
Verizon
VZ
|
$10.2M |
| 5 |
Starbucks
SBUX
|
$7.3M |
Top Sells
| 1 |
Atlassian
TEAM
|
$15M |
| 2 |
Fortinet
FTNT
|
$11.9M |
| 3 |
SIVB
SVB Financial Group
SIVB
|
$8.35M |
| 4 |
Palo Alto Networks
PANW
|
$8.14M |
| 5 |
Salesforce
CRM
|
$8.12M |
Sector Composition
| 1 | Healthcare | 27.45% |
| 2 | Financials | 26.95% |
| 3 | Technology | 16.16% |
| 4 | Consumer Discretionary | 9.02% |
| 5 | Consumer Staples | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Steris
STE
$23.8B
| $5.87M | 1.32% |
54,950
+49,000
| +824% | +$5.24M |
|
27
Intel
INTC
$105B
| $5.57M | 1.25% |
118,691
+108,000
| +1,010% | +$5.07M |
|
28
Crown Castle
CCI
$42.9B
| $4.96M | 1.11% |
45,650
+29,300
| +179% | +$3.18M |
|
|
GHDX
29
DELISTED
Genomic Health, Inc.
GHDX
| $4.74M | 1.06% |
73,600
+26,700
| +57% | +$1.72M |
|
30
Cigna
CI
$80.6B
| $4.72M | 1.06% |
+24,850
| New | +$4.72M |
|
|
AMED
31
DELISTED
Amedisys
AMED
| $4.5M | 1.01% |
38,450
-14,800
| -28% | -$1.73M |
|
32
TJX Companies
TJX
$154B
| $4.41M | 0.99% |
98,500
+6,300
| +7% | +$282K |
|
33
Progressive
PGR
$144B
| $3.75M | 0.84% |
62,200
-62,300
| -50% | -$3.76M |
|
34
Ciena
CIEN
$13.1B
| $3.7M | 0.83% |
+109,000
| New | +$3.7M |
|
35
American Tower
AMT
$94.3B
| $3.63M | 0.81% |
22,920
-200
| -0.9% | -$31.6K |
|
36
CSX Corp
CSX
$59.8B
| $3.6M | 0.81% |
58,000
-40,500
| -41% | -$2.52M |
|
37
Align Technology
ALGN
$9.87B
| $3.38M | 0.76% |
16,145
-32,650
| -67% | -$6.84M |
|
38
Arista Networks
ANET
$171B
| $3.36M | 0.76% |
15,970
-200
| -1% | -$42.1K |
|
39
AbbVie
ABBV
$373B
| $3.26M | 0.73% |
35,350
-200
| -0.6% | -$18.4K |
|
40
Becton Dickinson
BDX
$54.2B
| $3.21M | 0.72% |
14,247
-4,400
| -24% | -$991K |
|
|
HRC
41
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $3.19M | 0.72% |
+36,000
| New | +$3.19M |
|
42
Danaher
DHR
$144B
| $3.1M | 0.7% |
30,050
| – | – |
|
|
ABMD
43
DELISTED
Abiomed Inc
ABMD
| $2.99M | 0.67% |
9,200
-100
| -1% | -$32.5K |
|
44
Molina Healthcare
MOH
$9.96B
| $2.84M | 0.64% |
+24,400
| New | +$2.84M |
|
45
Edwards Lifesciences
EW
$47.9B
| $2.79M | 0.63% |
18,200
-300
| -2% | -$45.9K |
|
46
Ulta Beauty
ULTA
$23.5B
| $2.73M | 0.61% |
11,150
-15,600
| -58% | -$3.82M |
|
47
Henry Schein
HSIC
$8.32B
| $2.56M | 0.57% |
32,610
| – | – |
|
48
Veeva Systems
VEEV
$44B
| $2.43M | 0.55% |
27,200
-58,600
| -68% | -$5.23M |
|
49
Stryker
SYK
$149B
| $2.33M | 0.52% |
14,850
-500
| -3% | -$78.4K |
|
50
Fortive
FTV
$15.8B
| $2.2M | 0.49% |
+32,487
| New | +$2.2M |
|